Clinical Trial

Habitat Escalated Adaptive Therapy (HEAT), With Neoadjuvant Radiation for Soft Tissue Sarcoma

Name: Habitat Escalated Adaptive Therapy (HEAT), With Neoadjuvant Radiation for Soft Tissue Sarcoma — clinical trial record (NCT05301283)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of the study is to utilize radiomic images to precisely locate areas of tumor that can be treated with dose escalation radiation therapy.

Protocol Amendment History 18 amendments

This ClinicalTrials.gov record has been amended 18 times since 2022-03-18; most recent amendment 2025-12-03.

Trial Details

NCT Number	NCT05301283
Lead Sponsor	H. Lee Moffitt Cancer Center and Research Institute Collaborators: Viewray Inc.
Conditions	High Grade Sarcoma
Enrollment	43 participants
Start Date	2022-05-18
Primary Completion	2026-08 (estimated)
Study Completion	2026-08 (estimated)
Updated on ClinicalTrials.gov	2025-12-04